Crewe Advisors’s Bausch Health BHC Stock Holding History

Crewe Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-109	Closed	-$3K	–	299
2019 Q1	$3K	Buy	+109	New	+$2.6K	﹤0.01%	207
2018 Q2	–	Sell	-109	Closed	-$2K	–	256
2018 Q1	$2K	Hold	109	–	–	﹤0.01%	256
2017 Q4	$2K	Buy	+109	New	+$1.73K	﹤0.01%	254

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Crewe Advisors's BHC Position: Q2 2019 in Review

Crewe Advisors sold out of Bausch Health (BHC) in Q2 2019, closing a stake of 109 shares — an estimated $3K sold.

Crewe Advisors first reported a position in BHC in Q4 2017 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 332 funds tracked by Wall St. Rank hold BHC as of Q2 2019.

Crewe Advisors reported no remaining Bausch Health position as of Q2 2019 after selling out during the quarter.
Crewe Advisors sold 109 Bausch Health shares in Q2 2019, an estimated $3K.
Crewe Advisors first reported a position in Bausch Health in Q4 2017 and held it in 3 quarters.
Crewe Advisors's Bausch Health position peaked at $3K in Q1 2019.
332 funds tracked by Wall St. Rank held Bausch Health as of Q2 2019.

Based on Crewe Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.